Carl C. Dockery - 11 Aug 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Joshua R. Disbrow as attorney-in-fact for Carl Dockery
Issuer symbol
AYTU
Transactions as of
11 Aug 2023
Net transactions value
$0
Form type
4
Filing time
15 Aug 2023, 19:38:00 UTC
Previous filing
23 Dec 2022
Next filing
08 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +1,500 +20% $0.000000 8,940 11 Aug 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which vest as follows: 1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning on November 11, 2024.
F2 Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023.